Particularly, bexarotene was found to enhance the clearance of soluble Aβ within hours in an ApoE-dependent manner, to inhibit Aβ42 aggregation and reduce neuroinflammation, and to revert cognitive deficits [42–44] (Table 2). Here, APOE is linked to Cognitive impairment.